Prescription and over-the-counter medications
Pharmacy Plus, Inc.
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Pharmacy Plus, Inc.
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Pharmacy Plus, Inc.
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Pharmacy Plus, Inc.
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Pharmacy Plus, Inc.
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Pharmacy Plus, Inc.
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Pharmacy Plus, Inc.
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Pharmacy Plus, Inc.
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Pharmacy Plus, Inc.
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Pharmacy Plus, Inc.
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Subpotent Drug: Out of specification for assay
Chemical Contamination and CGMP Deviations: trace amounts of methanol found in one of the components during the manufacturing process.
cGMP Deviations: Out of specification for assay of one of the preservative ingredients.
Golden State Medical Supply
Label Mix - up; a bottle labeled as Atenolol 25mg Tablets contained Clopidogrel 75mg Tablets
Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration
Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration
CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.
Chemical Contamination and CGMP Deviations: trace amounts of methanol found in one of the components during the manufacturing process.
Boxes mislabeled to read "Decongestant Free", but the product contains Phenylephrine HCI 5mg
Golden State Medical Supply
Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).